Vermillion, Inc. (Nasdaq:VRML) a molecular diagnostics company, will host a web cast and conference call to give a company update following the issuance of the third quarter financial results on Wednesday, November 9, 2011.
Vermillion, Inc. and its subsidiaries engage in the discovery, development, and commercialization of diagnostics tests that help physicians to diagnose and treat patients.
Read the full article and the disclaimer at:http://bestotc.com/18774/stock-alerts/vrml-crwe-vtss-cers-stocks-in-action-by-bestotccom/
(VRML, CRWE, VTSS, CERS) Stocks in Action by BestOtc.com
October 17th, 2011 at 09:55 am